Amanote Research
Register
Sign In
Multitarget-Directed Drug Design Strategy: A Novel Molecule Designed to Block Epidermal Growth Factor Receptor (EGFR) and to Exert Proapoptotic Effects
doi 10.1021/jm0608762.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
BRAF; Epidermal Growth Factor Receptor (EGFR)
Science-Business eXchange
Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?
Breast Cancer Research
Cancer Research
Oncology
Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer
HPB
Hepatology
Gastroenterology
UBPY-mediated Epidermal Growth Factor Receptor (EGFR) De-Ubiquitination Promotes EGFR Degradation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Epidermal Growth Factor Receptor (EGFR); EGFR1 (HER1; ERBB1); EPH Receptor A2 (EPHA2)
Science-Business eXchange
Metabolic Disposition of Osimertinib in Rats, Dogs, and Humans: Insights Into a Drug Designed to Bind Covalently to a Cysteine Residue of Epidermal Growth Factor Receptor
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but Not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors
Cancer Research
Cancer Research
Oncology
Integrin Α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion Toward Hepatocyte Growth Factor (HGF)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology